News Sentiment

NKTX sentiment intelligence

Nkarta Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 52 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.97 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 44

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

-7.8% over one week, +3.8% over four weeks, trend active, and near fair-value range.

Latest direct headline Positive

Companies Like Nkarta (NASDAQ:NKTX) Are In A Position To Invest In Growth

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction -7.8% Price reacting lower
Trend fit Trend active 3.8% over four weeks
Fair value -18.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 34
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 44
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 10
Market source 8
TradingKey 8
simplywall.st 5
TradingView 4
Moomoo 2
Investing.com 2
MarketBeat 2

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 14
Analyst action 5
Regulatory and legal 3
Capital return 1
Balance sheet 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-52 of 52
Finviz Direct company coverage

NKTX - Nkarta Inc Stock Price and Quote

This article provides comprehensive financial data and news for Nkarta Inc (NKTX), a biopharmaceutical company focused on natural killer cell therapies. It details stock performance, key financial metrics, insider transactions, and a history of analyst ratings. Recent news highli

Tone
Neutral 50/100
Event
Analyst action
Published
05 Jun 2026 17:39
Source
Finviz
Zacks Investment Research Direct company coverage

Should I buy Nkarta (NKTX)

Tone
Positive 66/100
Event
Market update
Published
17 Apr 2026 07:00
Source
Zacks Investment Research